Lisdexamfetamine is a generic prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD) and binge eating disorder (BED). Lisdexamfetamine comes as an oral capsule ...

Patients were randomized to fixed-dose treatment groups that received final doses of 30, 50 or 70 mg of lisdexamfetamine dimesylate (as a capsule) or placebo once daily in the morning for 4 weeks 7.

Adjust Vyvanse dosage accordingly. High potential for abuse, misuse, and addiction; assess patient’s risk before prescribing. Assess for presence of cardiac disease before initiating.

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers.

Vyvanse (lisdexamfetamine) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat attention ...

Rutgers researchers found that lisdexamfetamine reduces binge episodes in binge eating disorder patients but has notable side effects, including insomnia and afternoon energy crashes. Some patients ...

Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

Lisdexamfetamine, marketed as Vyvanse, first received approval from the Food and Drug Administration for the treatment of ADHD, “but its ability to also reduce the frequency of binge eating ...